Litcius/Paper detail

Intravenous cyclophosphamide in acute exacerbation of rheumatoid arthritis-related interstitial lung disease: A propensity-matched analysis using a nationwide inpatient database

K Nakamura, Hiroyuki Ohbe, Kei Ikeda, Kazuaki Uda, Hiroki Furuya, Shunsuke Furuta, Mikio Nakajima, Yusuke Sasabuchi, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Hiroshi Nakajima

2021Seminars in Arthritis and Rheumatism27 citationsDOI

Topics & Concepts

MedicineInternal medicineRheumatoid arthritisPropensity score matchingOdds ratioExacerbationHazard ratioInterstitial lung diseaseConfidence intervalCyclophosphamideRetrospective cohort studyRheumatologyDatabaseLungChemotherapyComputer scienceInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisRheumatoid Arthritis Research and TherapiesSystemic Sclerosis and Related Diseases
Intravenous cyclophosphamide in acute exacerbation of rheumatoid arthritis-related interstitial lung disease: A propensity-matched analysis using a nationwide inpatient database | Litcius